Concepedia

Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator

Tomoki Wada, Hideo Yasunaga, Ryota Inokuchi, Hiromasa Horiguchi, Kiyohide Fushimi, Takehiro Matsubara, Susumu Nakajima, Naoki Yahagi

Journal of the Neurological Sciences · 2014 · 48 citations · 27 references

Concepts

ThrombosisCardiovascular DiseaseIschemic StrokeMedicinePharmacologyStroke-related ConditionCerebrovascular DiseaseEarly OutcomesVascular BiologyPharmacotherapyNeurologyCerebral Blood FlowPublic HealthStrokePlatelet AntagonistAtherosclerosisIschemic SyndromeReperfusion Injury

References

27

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group · New England Journal of Medicine · 1995 · 11.6K citations

Cerebrovascular Disease, Thrombosis, Stroke +17

Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score

Paul R. Rosenbaum, Donald B. Rubin · The American Statistician · 1985 · 4.8K citations

Treatment Effect, Causal Inference, Developmental Psychology +19

Constructing a Control Group Using Multivariate Matched Sampling Methods That Incorporate the Propensity Score

Paul R. Rosenbaum, Donald B. Rubin · The American Statistician · 1985 · 4.2K citations

Treatment Effect, Causal Inference, Developmental Psychology +19

Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction

Cerebrovascular Diseases · 2003 · 660 citations

Edaravone Group, Cerebrovascular Disease, Cerebral Vascular Regulation +19

NXY-059 for Acute Ischemic Stroke

Kennedy R. Lees, Justin A. Zivin, Tim Ashwood et al. · New England Journal of Medicine · 2006 · 655 citations